Major adverse cardiovascular outcomes within distinct pulmonary hypertension patterns in advanced chronic kidney disease: A retrospective cohort analysis
Andrew Geller , Jose Manuel Martinez Manzano , Simone A. Jarrett , Phuuwadith Wattanachayakul , John Malin , Raul Leguizamon , Tara A. John , Rasha Khan , Ian McLaren , Alex Prendergast , Kevin Bryan Lo , Christian Witzke , Glenn Eiger
{"title":"Major adverse cardiovascular outcomes within distinct pulmonary hypertension patterns in advanced chronic kidney disease: A retrospective cohort analysis","authors":"Andrew Geller , Jose Manuel Martinez Manzano , Simone A. Jarrett , Phuuwadith Wattanachayakul , John Malin , Raul Leguizamon , Tara A. John , Rasha Khan , Ian McLaren , Alex Prendergast , Kevin Bryan Lo , Christian Witzke , Glenn Eiger","doi":"10.1016/j.rmed.2024.107743","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"232 ","pages":"Article 107743"},"PeriodicalIF":3.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S095461112400218X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.